The DNA-binding domain of CaNdt80p is required to activate CDR1 involved in drug resistance in Candida albicans

Journal of Medical Microbiology

Volumn 55, Issue 10, 2006, Pages 1403-1411

  Wang, Jang Shiun ^a,b   Yang, Yun Liang ^c   Wu, Chin Jung ^c   Ouyang, Karen J ^c   Tseng, Kuo Yun ^b   Chen, Chia Geun ^b   Wang, Hsin ^c   Lo, Hsiu Jung ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHIMERIC PROTEIN; EFFLUX PUMP PROTEIN; FUNGAL PROTEIN; PROTEIN; PROTEIN CANDT80P; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SCNDT80P; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDT80 GENE; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 1; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; FUNGAL GENE; FUNGUS MUTANT; GENE ACTIVATION; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; CANDIDA ALBICANS; DNA, FUNGAL; DNA-BINDING PROTEINS; FUNGAL PROTEINS; GENETIC COMPLEMENTATION TEST; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINATION, GENETIC; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS;

EID: 33750483927     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46650-0     Document Type: Article

References (29)

1. Abi-Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H. & Vartivarian, S. (1997). The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24, 1122-1128.
2. Beck-Sague, C. & Jarvis, W. R. (1993). Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 167, 1247-1251.
3. Chen, Y. C., Chang, S. C., Sun, C. C., Yang, L. S., Hsieh, W. C. & Luh, K. T. (1997). Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 18, 369-375.
4. Chen, C. G., Yang, Y. L., Shin, H. I., Su, C. L. & Lo, H. J. (2004). CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother 48, 4505-4512.
5. Christianson, T. W., Sikorski, R. S., Dante, M., Shero, J. H. & Hieter, P. (1992). Multifunctional yeast high-copy-number shuttle vectors. Gene 110, 119-122.
6. Chu, S. & Herskowitz, I. (1998). Gametogenesis in yeast is regulated by a transcriptional cascade dependent on Ndt80. Mol Cell 1, 685-696.
7. Chu, S., DeRisi, J., Eisen, M., Mulholland, J., Botstein, D., Brown, P. O. & Herskowitz, I. (1998). The transcriptional program of sporulation in budding yeast. Science 282, 699-705.
8. Coste, A. T., Karababa, M., Ischer, F., Bille, J. & Sanglard, D. (2004). TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3, 1639-1652.
9. Edwards, E. J. J. (1990). Candida species. In Principles and Practice of Infectious Diseases, pp. 1943-1958. Edited by G. L. Mandell, R. G. Douglas & J. E. Bennett. London: Churchill-Livingstone.
10. Gillum, A. M., Tsay, E. Y. & Kirsch, D. R. (1984). Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198, 179-182.
11. Hung, C. C., Chen, Y. C., Chang, S. C., Luh, K. T. & Hsieh, W. C. (1996). Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 95, 19-28.
12. Karababa, M., Coste, A. T., Rognon, B., Bille, J. & Sanglard, D. (2004). Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48, 3064-3079.
13. Kofron, M., Demel, T., Xanthos, J. & 7 other authors (1999). Mesoderm induction in Xenopus is a zygotic event regulated by maternal VegT via TGFbeta growth factors. Development 126, 5759-5770.
14. Kohler, J. R. & Fink, G. R. (1996). Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc Natl Acad Sci U S A 93, 13223-13228.
15. Lopez-Ribot, J. L., McAtee, R. K., Lee, L. N., Kirkpatrick, W. R., White, T. C., Sanglard, D. & Patterson, T. F. (1998). Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 42, 2932-2937.
16. Marger, M. D. & Saier, M. H., Jr (1993). A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci 18, 13-20.
17. Michaelis, S. & Berkower, C. (1995). Sequence comparison of yeast ATP-binding cassette proteins. Cold Spring Harb Symp Quant Biol 60, 291-307.
18. Montano, S. P., Cote, M. L., Fingerman, I., Pierce, M., Vershon, A. K. & Georgiadis, M. M. (2002). Crystal structure of the DNA-binding domain from Ndt80, a transcriptional activator required for meiosis in yeast. Proc Natl Acad Sci U S A 99, 14041-14046.
19. Pak, J. & Segall, J. (2002). Regulation of the premiddle and middle phases of expression of the NDT80 gene during sporulation of Saccharomyces cerevisiae. Mol Cell Biol 22, 6417-6429.
20. Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B. & Wenzel, R. P. (1998). National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 30, 121-129.
21. Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S. & Hollis, R. J. (2000). Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 44, 747-751.
22. Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L. & Hollis, R. J. (2003). Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 41, 1440-1446.
23. Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1996). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40, 2300-2305.
24. Schaller, M., Bein, M., Korting, H. C., Baur, S., Hamm, G., Monod, M., Beinhauer, S. & Hube, B. (2003). The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun 71, 3227-3234.
25. Schmitt, M. E., Brown, T. A. & Trumpower, B. L. (1990). A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res 18, 3091-3092.
26. Sherman, F. (2002). Getting started with yeast. Methods Enzymol 350, 3-41.
27. Tapia, C., Leon, E. & Palavecino, E. (2003). Antifungal susceptibility of yeasts by Etest. Comparison of 3 media. Rev Med Chil 131, 299-302 (in Spanish).
28. Vanden Bossche, H., Warnock, D. W., Dupont, B. & 7 other authors (1994). Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol 32, 189-202.
29. Yang, Y. L. & Lo, H. J. (2001). Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect 34, 79-86.